Efficacy and survival analysis of nimotuzumab combined with concurrent chemoradiotherapy in the treatment of locally advanced nasopharyngeal carcinoma

Efficacy and survival analysis of nimotuzumab combined with concurrent chemoradiotherapy in the treatment of locally advanced nasopharyngeal carcinoma

ObjectiveThis study investigated the curative effect of adding nimotuzumab (NTZ) in patients with locally advanced nasopharyngeal carcinoma (NPC) who were treated with concurrent chemoradiotherapy (CCRT) and explored significant prognostic factors of NPC.Materials and methodsThe clinical data of 307...

Full description

Bibliographic Details
Main Authors:	Lili Wang, Hengzhao Zhuang, Xiaoyan Xu, Juying Zhou, Yang Jiao
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-02-01
Series:	Frontiers in Oncology
Subjects:	nasopharyngeal carcinoma nimotuzumab concurrent chemoradiotherapy survival outcome propensity score matching
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1129649/full

Similar Items

Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy with or without nimotuzumab in the treatment of locally advanced nasopharyngeal carcinoma: a retrospective study
by: Zhi Yang, et al.
Published: (2023-11-01)

Effect of Endostar combined with concurrent chemoradiotherapy in patients with locally advanced cervical cancer
by: Hengzhao Zhuang, et al.
Published: (2023-06-01)

Comparison of radiotherapy combined with nimotuzumab vs. chemoradiotherapy for locally recurrent nasopharyngeal carcinoma
by: Jing-Feng Zong, et al.
Published: (2021-11-01)

Effectiveness and cost-effectiveness analysis of nimotuzumab for the radiotherapy of locoregionally advanced nasopharyngeal carcinoma
by: Zhaodong Fei, et al.
Published: (2020-10-01)

Addition of nimotuzumab to concurrent chemoradiotherapy after induction chemotherapy improves outcomes of patients with locally advanced nasopharyngeal carcinoma
by: Run-Jie Wang, et al.
Published: (2024-03-01)

Hematological Toxicities of Concurrent Chemoradiotherapies in Head and Neck Cancers: Comparison Among Cisplatin, Nedaplatin, Lobaplatin, and Nimotuzumab
by: Qiuji Wu, et al.
Published: (2021-10-01)

Induction chemotherapy plus nimotuzumab followed by concurrent chemoradiotherapy for advanced nasopharyngeal carcinoma
by: Xinmao Song, et al.
Published: (2019-07-01)

Concurrent chemoradiotherapy with weekly docetaxel versus cisplatin in the treatment of locoregionally advanced nasopharyngeal carcinoma: a propensity score-matched analysis
by: Jun-Fang Liao, et al.
Published: (2019-06-01)

Comparison of weekly and triweekly cisplatin regimens during concurrent chemoradiotherapy for nasopharyngeal carcinoma
by: Kailin Wang, et al.
Published: (2019-05-01)

Modeling Sarcopenia to Predict Survival for Patients With Nasopharyngeal Carcinoma Receiving Concurrent Chemoradiotherapy
by: Xin Hua, et al.
Published: (2021-03-01)

Survival of stage II nasopharyngeal carcinoma patients with or without concurrent chemotherapy: A propensity score matching study
by: Di‐Han Liu, et al.
Published: (2020-02-01)

The efficacy and safety of induction chemotherapy combined with concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in nasopharyngeal carcinoma patients: a systematic review and meta-analysis
by: Bi-Cheng Wang, et al.
Published: (2020-05-01)

Changes in T lymphocyte subsets in peripheral blood of patients with middle-advanced cervical cancer before and after nimotuzumab combined with concurrent chemoradiotherapy
by: Man Ao, et al.
Published: (2023-12-01)

The impairment of induction chemotherapy for stage II nasopharyngeal carcinoma treated with intensity‐modulated radiotherapy with or without concurrent chemotherapy: A propensity score‐matched analysis
by: YuLin Lai, et al.
Published: (2023-02-01)

Efficacy of concurrent chemoradiotherapy plus Endostar compared with concurrent chemoradiotherapy in the treatment of locally advanced nasopharyngeal carcinoma: a retrospective study
by: Yuanxiu Yin, et al.
Published: (2022-07-01)

Efficacy of concurrent chemoradiotherapy in subgroups of stage III nasopharyngeal carcinoma: an analysis based on 10-year follow-up
by: Lei Wang, et al.
Published: (2021-11-01)

Radiotherapy Alone Versus Concurrent or Adjuvant Chemoradiotherapy for Nasopharyngeal Carcinoma Patients with Negative Epstein–Barr Virus DNA after Induction Chemotherapy
by: Fangfang Kong, et al.
Published: (2023-03-01)

Efficacy and Safety of Concurrent Chemoradiotherapy Combined With Induction Chemotherapy or Adjuvant Chemotherapy in Patients With Stage II–IVA Nasopharyngeal Carcinoma: A Propensity Score Matching Analysis and Meta-Analysis
by: Jie Yang, et al.
Published: (2021-12-01)

Stage-specific concurrent chemoradiotherapy with or without induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma: a retrospective, population-based study
by: Xia WX, et al.
Published: (2019-11-01)

Weekly versus triweekly cisplatin treatment in patients with locally advanced nasopharyngeal cancer during concurrent chemoradiotherapy
by: Xin Li, et al.
Published: (2023-10-01)

The Clinical Outcomes of Locally Advanced Cervical Esophageal Squamous Cell Carcinoma Patients Receiving Curative Concurrent Chemoradiotherapy: A Population-Based Propensity Score-Matched Analysis
by: Yen-Hao Chen, et al.
Published: (2019-03-01)

The long-term survival of patients with III-IVb stage nasopharyngeal carcinoma treated with IMRT with or without Nimotuzumab: a propensity score-matched analysis
by: Wang Zhi-Qiang, et al.
Published: (2019-11-01)

Nimotuzumab Combined with Induction Chemotherapy and Concurrent Chemoradiotherapy in Unresectable Locally Advanced Hypopharyngeal Carcinoma: A Single Institution Experience in China
by: Tian X, et al.
Published: (2020-05-01)

The Double-Edge Role of the Addition of Adjuvant Chemotherapy to Concurrent Chemoradiotherapy in the Treatment of Nasopharyngeal Carcinoma
by: Liang ZG, et al.
Published: (2020-02-01)

Safety and efficacy analysis of chemoradiotherapy/radiotherapy combined with nimotuzumab for treating unresectable oesophageal squamous cell carcinoma in elderly patients: a retrospective analysis
by: Yu Zhang, et al.
Published: (2022-12-01)

Nimotuzumab combined with chemoradiotherapy for the treatment of cervical cancer: A meta-analysis of randomized controlled trials
by: Yan Yuan, et al.
Published: (2022-10-01)

Prognostic significance of the novel nutrition-inflammation marker of lymphocyte–C-reactive protein ratio in patients with nasopharyngeal carcinoma receiving concurrent chemoradiotherapy
by: Xin Hua, et al.
Published: (2023-07-01)

Quality of life (QOL) in patients suffering from locally advancedstage nasopharyngeal cancer before, during and after receiving carboplatin with concurrent chemoradiotherapy
by: Kanyarat Chuchart, et al.
Published: (2010-06-01)

Inflammation-based prognostic scores predict the prognosis of locally advanced cervical esophageal squamous cell carcinoma patients receiving curative concurrent chemoradiotherapy: a propensity score-matched analysis
by: Chia-Che Wu, et al.
Published: (2018-09-01)

High Pretreatment Platelet-to-Albumin Ratio Predicts Poor Survival Results in Locally Advanced Nasopharyngeal Cancers Treated with Chemoradiotherapy
by: Haksoyler V, et al.
Published: (2021-07-01)

Central pontine myelinolysis (CPM) and extrapontine myelinolysis (EPM) following concurrent chemoradiotherapy for nasopharyngeal carcinoma
by: Chen-Hui Chong, et al.
Published: (2016-06-01)

Impact of induction chemotherapy with concurrent chemoradiotherapy on nasopharyngeal carcinoma: A meta-analysis of randomized controlled trials
by: Ting-Chieh Huang, et al.
Published: (2022-09-01)

Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma
by: Jiraporn Setakornnukul, et al.
Published: (2018-03-01)

Clinical efficacy of adjuvant chemotherapy for locally advanced nasopharyngeal carcinoma
by: YANG Xiu, et al.
Published: (2022-11-01)

Radiosensitivity enhancement by combined treatment of nimotuzumab and celecoxib on nasopharyngeal carcinoma cells
by: Huang JF, et al.
Published: (2018-07-01)

Low Skeletal Muscle Mass Impairs Quality of Life in Nasopharyngeal Carcinoma Patients Treated With Concurrent Chemoradiotherapy
by: Xin Hua, et al.
Published: (2020-01-01)

Development and prospective validation of a risk score model in guiding individualized concurrent chemoradiotherapy in stage II nasopharyngeal carcinoma in intensity‐modulated radiotherapy era
by: Shan‐Shan Yang, et al.
Published: (2022-02-01)

The detrimental effects of radiotherapy interruption on local control after concurrent chemoradiotherapy for advanced T-stage nasopharyngeal carcinoma: an observational, prospective analysis
by: Ji-Jin Yao, et al.
Published: (2018-07-01)

Pretreatment Photopenia on 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Scans Predicts Poor Prognosis in Nasopharyngeal Cancer Patients Undergoing Concurrent Chemoradiotherapy
by: Erkan Topkan, et al.
Published: (2020-11-01)

The Application of Nimotuzumab Combined With Definitive Chemoradiotherapy Toward the Treatment of Locally Advanced Cervical Esophageal Carcinoma: A Retrospective Study
by: Jing Hu, et al.
Published: (2022-07-01)